equity analyst

CAROLINE YASUKO STEWART

*** ****** ***, *********, ** 07631 ? 917-***-**** ?

********.*.*******@*****.***

EXPERIENCE

H.C. Wainwright & Co., LLC, New York, NY

Managing Director, Senior Biotech Analyst, Jul 2013-Nov 2013

. Companies under coverage: Ariad, Neurocrine Biosciences, Clovis

Oncology, Celsion, OvaScience

SANOFI, Bridgewater, NJ

Senior Manager, US Finance, 2012-2013

. Responsible for forecasting US sales of oncology and transplant

products (Mozobil, Thymoglobulin, Leukine and Clolar) using data from

Kantar Health and utilizing tools such as Crystal Ball, as well as

interacting with brand marketing heads and the respective trade

groups.

. Valuation analyses of potential business development deals in the

oncology and transplant areas.

MSMB Capital Management LLC, New York, NY

Consultant, 2010-2011

. Global biotech analyst with responsibility for making long/short

recommendations.

MERCK KGAA, Darmstadt, Germany

Director, Investor Relations, 2009-2010

. Primary responsibility for Merck Serono pharmaceuticals, US investor

relationships (Goldman Sachs, Merrill Lynch, Morgan Stanley, Sanford

Bernstein, Piper Jaffray) and Japan (Nomura).

PIPER JAFFRAY, New York, NY

Senior Biotechnology Analyst, V.P., 2006-2009

. Companies under coverage: Biogen Idec, Elan, Alexion, OSI

Pharmaceuticals, Acorda, Pain Therapeutics, Durect, ImClone,

Progenics, Cougar Biotechnology, Medivation, Neurochem, Adolor,

Oscient, Transition Therapeutics.

. Wall Street Journal "Best On The Street" (#4) and Financial Times /

Starmine #3 Best Stock Picker 2008

MORGAN JOSEPH / IRG, New York, NY

Vice President, Analyst, 2004-2006

. Biotechnology companies under coverage: Arena Pharmaceuticals,

Transkaryotic Therapies, Incyte, Abgenix, Progenics, Metabasis,

Antigenics, CV Therapeutics.

. Firm banking: Arena Pharmaceuticals (Morgan Joseph co-manager, $45mm

secondary offering Feb '05)

SALOMON SMITH BARNEY, New York, NY

Associate, 2002-2003 & 1998-2000

. Primary responsibility for: Amgen, Biogen, Chiron, Genentech, Genzyme,

Gilead, IDEC, MedImmune, Neurocrine Biosciences.

DEUTSCHE BANC SECURITIES, New York, NY

Associate, 2001-2002

. Primary responsibility for: Amgen, MedImmune, Millennium

Pharmaceuticals, Incyte Pharmaceuticals, Transkaryotic Therapies, CV

Therapeutics, Genaissance Pharmaceuticals and Diversa.

HARVARD UNIVERSITY, Cambridge, MA

Pforzheimer House Resident Tutor, 1994-1998

EDUCATION

Brandeis University, Waltham, MA

M.S., Molecular and Cell Biology, 1997 / M.S., Chemistry, 1993

Columbia University/Barnard College, New York, NY

Bachelor of Arts, Chemistry, 1992

OTHER

Fluent in Japanese; familiar with Russian. Licensed investment

professional, Series 7, 63, 86 & 87.

Contact this candidate